Cholecystectomy. Cholecystitis
Conditions
Interventions
Intervention 1: In intervention group Lidocaine (each ampoule contains 20 mg/ml Lidocaine, made by Daroopakhsh Co - Iran) with primary dose of 0.5 mg/kg and maintenance dose of 2 mg/kg/h is administer
Treatment - Drugs
Placebo
In intervention group Lidocaine (each ampoule contains 20 mg/ml Lidocaine, made by Daroopakhsh Co - Iran) with primary dose of 0.5 mg/kg and maintenance dose of 2 mg/kg/h is administered.
In control group placebo (normal saline) is administered.
Sponsors
Deputy of Research Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are patient willingness to participation, ASA (American Society of Anesthesiologists) classification of I or II and elective laparoscopy. Exclusion criteria are history of sensitivity to local analgesics, long-lasting use of narcotics and steroids, pregnancy and history of cardiac or other chronic diseases and high blood pressure, age less than18 or more than 85, BMI more than 40, HR less than 50 and PR interval more than 0.2 sec. or any kind of cardiac block.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: before and after operation. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: every 5 minutes and every 15 minutes in PACU. Method of measurement: digital monitoring device.;Heart Rate. Timepoint: every 5 minutes and every 15 minutes in PACU. Method of measurement: digital monitoring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHssein Sattari
Kerman University of Medical Sciences
Outcome results
None listed